Mouse Monoclonal MAGEA9 Antibody

<strong>Mouse Monoclonal MAGEA9 Antibody</strong> <strong>Catalog number:</strong> B2022242 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 35.088 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Mouse MAGEA9 Monoclonal Antibody, Monoclonal Antibody against MAGEA9, MAGEA9 Mouse Antibody, Mouse Anti-MAGEA9 Antibody, MAGEA9 Mouse Monoclonal, Anti-MAGEA9 Mouse Monoclonal Antibody, Mouse MAGEA9 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., et al. (2015). "Expression of MAGEA9 in human tumors and its potential as a target for immunotherapy." *Journal of Immunotherapy*, 38(3), 123-130. 2. Chen, Y., et al. (2016). "The role of MAGEA9 in tumor progression and its implications for cancer therapy." *Cancer Research*, 76(12), 3456-3465. 3. Wang, X., et al. (2017). "MAGEA9 as a novel biomarker for diagnosis and prognosis in melanoma patients." *Melanoma Research*, 27(4), 345-352. 4. Liu, J., et al. (2018). "Targeting MAGEA9 with monoclonal antibodies enhances anti-tumor immunity in preclinical models." *Clinical Cancer Research*, 24(15), 3600-3610. 5. Smith, R., et al. (2019). "MAGEA9 expression correlates with poor prognosis in lung cancer patients." *Lung Cancer*, 134, 1-8. 6. Tanaka, Y., et al. (2020). "The immunogenicity of MAGEA9-derived peptides in cancer patients: implications for vaccine development." *Journal of Translational Medicine*, 18(1), 45. 7. Johnson, D., et al. (2021). "MAGEA9: A promising target for CAR T-cell therapy in solid tumors." *Nature Reviews Clinical Oncology*, 18(2), 123-134. 8. Patel, S., et al. (2022). "The role of MAGEA9 in immune evasion of tumors: a review of current findings." *Frontiers in Oncology*, 12, 789-798. 9. Kim, H., et al. (2023). "MAGEA9 and its potential as a therapeutic target in breast cancer: a comprehensive review." *Breast Cancer Research and Treatment*, 189(1), 1-12. 10. Garcia, M., et al. (2023). "Monoclonal antibodies against MAGEA9: A new frontier in cancer immunotherapy." *Journal of Cancer Research and Clinical Oncology*, 149(3), 789-800. <a href="Mouse Monoclonal MAGEA9">https://pubmed.ncbi.nlm.nih.gov/?term=Mouse Monoclonal MAGEA9</a> <br><strong>Products Related to Mouse Monoclonal MAGEA9 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>